The new round of awards for the U.S. Department of Defense Congressionally Directed Medical Research Programs is now open. All organizations, including foreign organizations, foreign public entities, and international organizations, are eligible to apply.
The Hepatitis B Foundation advocated to ensure that hepatitis B is one of the diseases included in these programs, and we also worked with DoD to recruit hepatitis B advocates and patients to serve on the review committees.
These are excellent funding opportunities for hepatitis B research, and it is critical that researchers apply to these funds – the more applications they receive, the higher hepatitis B will be prioritized, and the less chance that hepatitis B will be taken off the disease list in the future. Since its initial inclusion, over $3.48 million has been awarded to hepatitis B grants through this competitive program, and over $28 million has been awarded for liver cancer research.
Consider submitting an application. More details from the DoD can be found below, and at https://cdmrp.army.mil/